2310022A10Rik Activators
2310022A10Rik activators encompass a range of chemical compounds that enhance the protein's activity through distinct signaling mechanisms. For example, cAMP, along with its analog 8-Bromo-cAMP, elevate intracellular signaling cascades that involve the activation of PKA. This activation can lead to the phosphorylation of proteins in pathways that 2310022A10Rik is a part of, enhancing its activity. Forskolin, by directly stimulating adenylyl cyclase, also raises cAMP levels, which indirectly promotes 2310022A10Rik activity through the same PKA-mediated pathway. Similarly, PMA activates PKC, which can phosphorylate proteins within the signaling pathways of 2310022A10Rik, thus indirectly enhancing its activity. Ionomycin and A23187, both calcium ionophores, increase intracellular calcium levels, impacting calcium-dependent kinases and phosphatases that could,modify 2310022A10Rik's activity. Additionally, Sphingosine-1-phosphate operates through receptor-mediated pathways that can initiate a signaling cascade, possibly leading to the enhanced activity of 2310022A10Rik.
Further augmenting the activity of 2310022A10Rik, Bisindolylmaleimide I, through its inhibition of PKC, might indirectly enhance 2310022A10Rik pathways by shifting cellular kinase activity. In the realm of polyphenols, EGCG's inhibition of certain tyrosine kinases alters phosphorylation states within signaling pathways, which could lead to the enhanced activation of 2310022A10Rik. Inhibitors like Wortmannin and U0126, targeting PI3K and MEK1/2 respectively, can redirect signaling through alternative routes that may converge on 2310022A10Rik activation. SB203580, by specifically inhibiting p38 MAPK, also has the potential to alter signaling dynamics in favor of pathways involving 2310022A10Rik. Together, these activators utilize a complex network of cellular signaling modifications to enhance the functional activity of 2310022A10Rik without directly increasing its expression or requiring direct interaction with the protein.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
cAMP acts as a secondary messenger in many biological processes. It activates protein kinase A (PKA), which can then phosphorylate target proteins, potentially including 2310022A10Rik, thus enhancing its functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC) which is involved in numerous signaling pathways. Activation of PKC may lead to the phosphorylation and activation of proteins downstream or within the same pathway as 2310022A10Rik. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
This cAMP analog is resistant to degradation by phosphodiesterases and can persistently activate PKA. Sustained PKA activity may enhance the functional activity of 2310022A10Rik by phosphorylation or by modulation of the signaling environment. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations, potentially affecting calcium-dependent protein kinases and phosphatases that could interact with or modify the activity of 2310022A10Rik. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
As a specific inhibitor of PKC, Bisindolylmaleimide I can shift the balance of kinase activity within the cell, potentially favoring the activation of alternate pathways that may enhance the activity of 2310022A10Rik. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that can inhibit certain tyrosine kinases, potentially altering the phosphorylation state of proteins within signaling pathways that include 2310022A10Rik, leading to its enhanced activation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium, which could activate calcium/calmodulin-dependent protein kinases that may subsequently enhance the activity of 2310022A10Rik. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P is a bioactive lipid that activates sphingosine-1-phosphate receptors, potentially initiating signaling cascades that result in the activation of 2310022A10Rik. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is an inhibitor of phosphoinositide 3-kinases (PI3K), and by altering the PI3K/AKT pathway, it could modify the activity of proteins within these pathways, potentially enhancing the activity of 2310022A10Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK, and by inhibiting this kinase, it could lead to the activation of alternative signaling pathways that involve the protein 2310022A10Rik. | ||||||